ArticlePloS one2025
Characterization of Congregicoccus parvus gen. nov., sp. nov., a novel slow-growing ultramicrobacterium of the phylum Verrucomicrobiota.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Physiology, functional genomics, and proteomics ofApplied and environmental microbiology · 2026Article
- Diversity of Bacteria.Progress in molecular and subcellular biology · 2026Review
- Validation List no. 226: valid publication of new names and new combinations effectively published outside theInternational journal of systematic and evolutionary microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bacterial phylum Verrucomicrobiota is a typical representative of challenging-to-culture lineages. Here, we isolated a novel slow-growing Verrucomicrobiota bacterium, designated ASA1T, from garden soil. Phylogenetic analyses suggested that strain ASA1T was affiliated with a novel candidate in the family Alterococcaceae of the class Opitutia (previously Opitutae), exhibiting low 16S rRNA gene sequence identities (<93%) and average nucleotide identity values (<77%) to the closest type strain. Furthermore, average amino acid identity analysis (AAI) showed that ASA1T shares <54% AAI identity with Opitutia representatives, well below the 60-65% genus threshold, supporting its classification as a novel genus. In addition to its genomic characteristics, ASA1T exhibits distinctive morphological features, including an ultramicrobacterial cell size (0.05-0.07 μm3) and cluster-like aggregation (>10 µm). Strain was Gram-negative, aerobic, and motile, with menaquinone-7 as its primary respiratory quinone and a fatty acid profile dominated by anteiso-C15:0 (53%) and C16:0 (15%). Based on these results, we propose that strain ASA1T represents a novel genus and species named Congregicoccus parvus gen. nov., sp. nov. (JCM 36569T = NCIMB 15508T) of the Alterococcaceae family. Habitability analysis suggested that ASA1T relatives were distributed in the soil and other environments, such as freshwater and activated sludge. Additional genome analysis of strain ASA1T revealed six unique biosynthetic gene clusters with no related clusters identified via antiSMASH, suggesting a potential source of novel bioactive compounds for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.